COMMUNIQUÉS West-GlobeNewswire

Wake Radiology Welcomes New Director of Business Development, Bonnie Little-Hildebrandt, MHA
10/10/2024
Raleigh, N.C., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, the leading provider of outpatient medical imaging in the Triangle, is pleased to announce Bonnie Little-Hildebrandt, MHA, has joined [...]
The Black Car Fund Partners with CirrusMD to Provide 24/7 Virtual Primary Care to Tens of Thousands of Eligible Drivers in New York State at No-Cost
10/10/2024
Provides accessible healthcare to over 55,000 black car and rideshare drivers DENVER and NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- CirrusMD, creator of Physician-first Care & Guidance, a new model for virtual [...]
CenTrak Named Global Healthcare RTLS Company of the Year by Frost & Sullivan
10/10/2024
CenTrak recognized as a global RTLS leader for its scalable location data and comprehensive suite of solutions on a unified platform, enhanced by expert clinical support NEWTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- [...]
Spinach® Is the Number One Cannabis Brand in Canada
10/10/2024
TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is proud to announce that its award-winning brand Spinach® has risen to the [...]
Amydis to Present First Ocular Tracer Designed to Detect Transthyretin Amyloidosis (ATTR) at AAOOP Conference
10/10/2024
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease-related molecular biomarkers in the eye, announced [...]
Labviva Named BostInno Fire Awards Honoree
10/10/2024
Company acknowledged for “pushing AI to the limits” BOSTON, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Labviva , the leading AI procurement platform for life sciences, was named as an honoree of the 2024 BostInno Fire Awards in [...]
NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially
10/10/2024
LANGHORNE, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
International Myeloma Foundation Launches Clinical Trial Matching Engine in Partnership with SparkCures
10/10/2024
SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org. STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to [...]
Alpha Tau Treats First Patient with Recurrent Lung Cancer
10/10/2024
JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , announced today [...]
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics
10/10/2024
DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic [...]
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
10/10/2024
Company’s VP of Education and Global Training Named Chairman of ASRM Corporate Member Council ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing [...]
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)
10/10/2024
– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical Trial Application (CTA) – The study is a Phase 1 Single Ascending Dose (SAD) /Multiple Ascending Dose ( [...]
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
10/10/2024
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced [...]
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
10/10/2024
FDA approval for the IND submission to conduct its trial already secured Vancouver, Canada, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a [...]
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
10/10/2024
ROCKVILLE, Md., Oct. 10, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
10/10/2024
Boston (October 10, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that [...]
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
10/10/2024
Media Release SYDNEY, AUSTRALIA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for [...]
Construction of JinMed's New Facility Begins in Chuzhou, China
10/10/2024
Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), an industrial leader in Assistive Technologies (“AT”), and a manufacturer and developer [...]
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
10/10/2024
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects revenue for the third [...]

Pages